Chugai Pharmaceutical Co.
13Patents
6Active
13Granted
41Portfolio score
Filing activity: Jan 24, 1994 → Mar 9, 2017 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6024956A | Method to treat inflammation with humanized anti-IL-8-antibodies | Chemistry; Metallurgy | 41 | Expired |
| US5866341A | Compositions and methods for screening drug libraries | Chemistry; Metallurgy | 36 | Expired |
| US5968784A | Method for analyzing quantitative expression of genes | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6068840A | Recombinant CDR-grafted and chimeric anti-IL-8 antibodies containing CDRs or the variable region from the mouse monoclonal antibody, WS-4 | Chemistry; Metallurgy | 8 | Expired |
| US5707621A | Supression of nephritis-induced protein excretion by anti-IL-8 | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5464828A | Aqueous suspension of sucralfate | Human Necessities | 6 | Expired |
| US6048972A | Recombinant materials for producing humanized anti-IL-8 antibodies | Chemistry; Metallurgy | 4 | Expired |
| US8568737B2 | Screening methods using G-protein coupled receptors and related compositions | Physics | 2 | Active |
| US9057727B2 | Screening methods using G-protein coupled receptors and related compositions | Physics | 1 | Active |
| US11104668B2 | Inhibitors of bruton's tyrosine kinase | Chemistry; Metallurgy | 0 | Active |
| US9556150B2 | Inhibitors of bruton's tyrosine kinase | Chemistry; Metallurgy | 0 | Active |
| US9624201B2 | Inhibitors of bruton's tyrosine kinase | Chemistry; Metallurgy | 0 | Active |
| US10093657B2 | Inhibitors of bruton's tyrosine kinase | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.